Adient: The Unimpacted Negative FCF Highlights The Structural Issues

Adient remains a hold with a revised price target of $18.5/share due to structural and execution risks. The company's China strategy has eroded margins, with Asia margins dropping over 300 bps and free cash flow turning negative. Net debt exceeds market cap, at $1.7B vs $1.56B.